Neuroone Medical Technologies Corp
NMTC- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001500198
In the last 90 days, Neuroone Medical Technologies Corp insiders filed 1 open-market purchase and 0 sales; 26 institutions reported holding it in 13F filings for Q2 2026, worth $6.21M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Neuroone Medical Technologies Corp changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 11 | 1 | 12 | +2 |
| Shares | 1.84M | 50.0K | 1.77M | −20.3K (−1.1%) |
| Value | $1.51M | $41.0K | $2.99M | +$1.52M (+103.1%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Neuroone Medical Technologies Corp at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| MAI Capital Management | 50,000 | $85.0K | 0.00% |
| State Street Corp | 35,899 | $61.0K | 0.00% |
| Jane Street Group, LLC | 20,282 | $34.0K | 0.00% |
| Newport Capital Group, LLC | 18,348 | $24.0K | 0.01% |
Sold out (2)
Institutions that held Neuroone Medical Technologies Corp at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Kingsbury Capital Investment Advisors LLC | 53,403 | $44.0K |
| UBS Group AG | 881 | $1.00K |
Not filed for Q3 2022 yet (1)
Institutions that held Neuroone Medical Technologies Corp at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Intersect Capital LLC | 50,000 | $41.0K |